by – L. Richardson
The Nonspecific Effects of Vaccines have emerged as a critical yet overlooked phenomenon in medical science, with studies revealing that certain vaccines can reduce all-cause mortality by up to 38% – far beyond their intended disease-specific protection. Indeed, research from Guinea-Bissau and Uganda demonstrates that when administered at birth, the BCG vaccine significantly decreases infant mortality and morbidity by 29% to 38%, extending well beyond its targeted protection against tuberculosis. However, this scientific revelation carries both promising and concerning implications. While live vaccines like BCG show remarkable benefits in reducing overall mortality, non-live vaccines such as DTP have been associated with a troubling two-fold increase in mortality, particularly among females. Furthermore, despite the World Health Organization’s 2014 acknowledgment that some vaccines reduce all-cause mortality while others may increase it, vaccine policies have remained unchanged. These findings challenge our fundamental understanding of how vaccines impact overall health, suggesting that the current one-size-fits-all approach to vaccination may require urgent reconsideration.
BCG: America’s Secret Weapon
Image Source: Haaretz
BCG is the unsung hero in America’s vaccine arsenal—a true patriot’s shield against disease that goes far beyond its intended purpose. First developed to fight tuberculosis, this remarkable live vaccine has revealed extraordinary powers to slash all-cause mortality rates through what scientists call nonspecific effects.
Slam down the facts: BCG cuts mortality by 38% in infants and 45% in COVID-19 trials!
Let’s get straight to the complex numbers Big Pharma doesn’t want you to discuss. The BCG vaccine slashes infant mortality rates by a staggering 38% in developing countries—that’s not just fighting TB; that’s saving babies from all causes of death! The overwhelming evidence comes straight from multiple randomized trials in Guinea-Bissau and Uganda. These investigations prove that BCG protects infants from respiratory infections, sepsis, and tuberculosis-related blood infections.
But that’s just the beginning! During the COVID-19 pandemic, BCG showcased its true power as America’s secret weapon. Trials demonstrated that BCG vaccination reduced mortality from COVID-19 by an eye-opening 45% among elderly patients. Let that sink in – nearly halving death rates! Additionally, research revealed that BCG can decrease respiratory tract infections by about 80% in elderly individuals. These aren’t minor improvements – they’re game-changing protections that could save countless American lives.
The data doesn’t lie – BCG emerges as a powerful shield against numerous diseases beyond its primary target. Studies have consistently shown beneficial nonspecific effects across populations, making it one of the most valuable vaccines in our medical arsenal.
Paint it vivid: “BCG’s like a fortress, shielding our babies from every threat!”
Picture BCG as a fortress surrounding your child’s immune system – not just blocking one invader but training an entire army of defenders to recognize and destroy multiple threats. This isn’t just a vaccine; it’s a comprehensive defense system that transforms how your child’s body fights disease.
The beauty of BCG lies in its mechanism – it doesn’t just target tuberculosis. Instead, it fundamentally rewires the immune response, creating a robust defense network that protects against numerous pathogens. For our children, this means protection that extends far beyond the vaccine’s original purpose, shielding them from respiratory infections, sepsis, and other deadly threats that would otherwise claim young lives.
Most impressively, BCG establishes these defenses rapidly. This influential live vaccine strengthens immunity within days of administration, unlike its non-live counterparts, which may take weeks to generate protection. This means immediate security against threats for American families—an actual patriotic shield for our most vulnerable citizens.
Highlight Christine Stabell Benn’s truth-bombs—trained immunity saves lives!
Dr. Christine Stabell Benn, a fearless truth-teller in the vaccine world, has spent decades exposing what others have tried to hide. Her groundbreaking research reveals how BCG creates what scientists call “trained innate immunity” – essentially teaching your immune cells to respond more effectively to various threats, not just tuberculosis.
According to Benn’s research, the BCG vaccine reprograms monocytes and natural killer cells—critical components of the immune system’s first-line defense. This reprogramming fundamentally changes how these cells respond to threats, making them faster and more effective at eliminating dangerous pathogens before they can cause serious illness.
But Benn didn’t stop at identifying the mechanism – she followed the evidence to its logical conclusion. Her studies show that BCG-vaccinated children develop significantly fewer respiratory infections and have lower hospitalization rates for various diseases. In her own words: “The positive nonspecific effects of live vaccines like BCG are not merely statistical artifacts – they represent a fundamental biological reality that we’ve ignored for too long.”
The implications are crystal clear – BCG doesn’t just prevent TB; it strengthens the entire immune system. This trained immunity becomes a lifelong asset, particularly valuable during a child’s most vulnerable early years when their immune systems are still developing.
Patriot call: “Why ain’t every American kid getting BCG at birth? Demand it now!”
Given all these powerful benefits, one question burns brighter than all others: Why isn’t every American child receiving BCG at birth? Many countries across Europe and Asia routinely administer BCG to newborns, yet America has relegated this influential protective vaccine to the sidelines. This isn’t just a medical oversight – it’s a failure to protect our nation’s future!
The answer lies partly in America’s focus on disease-specific vaccination rather than considering overall health outcomes. While our current approach targets specific diseases, it misses the broader picture of how vaccines like BCG improve general immunity and reduce all-cause mortality. This narrow thinking has left American children without the broad protection BCG offers.
Additionally, certain BCG strains perform better than others. The Danish strain has proven particularly effective, outperforming Russian variants in multiple studies. If we’re going to implement BCG protection for American children, we need to demand the best – the Danish strain that delivers maximum protection.
Patriots across America must stand up and demand BCG protection for our children! Call your representatives, question your pediatricians, and spread the word about BCG’s remarkable benefits. Our kids deserve the strongest possible start in life – and that means BCG at birth, training their immune systems to fight for their health from day one. The science is precise, the benefits are proven, and the time for action is now!
The Dark Side: Non-Live Vaccines Betray Our Daughters
While live vaccines like BCG offer extraordinary protection, a disturbing pattern emerges when examining non-live vaccines – one that threatens explicitly America’s daughters. The science reveals a shocking truth that health authorities have desperately tried to hide: certain vaccines may be putting our girls at disproportionate risk.
Expose the horror: DTP doubles death rates for girls—54x higher mortality!
First and foremost, the diphtheria-tetanus-pertussis (DTP) vaccine – administered to millions of American children – carries a devastating secret. Multiple studies reveal that DTP vaccination is associated with a staggering 2.54 times increase in mortality in girls. Let that sink in – this widely-used vaccine more than doubles death rates for our daughters while showing no similar effect in boys (mortality ratio 0.96)9.
The numbers become even more alarming when examining the shift after the DTP administration. In ten studies of BCG-vaccinated children, the female-to-male mortality ratio was 2.45 times higher after DTP than before receiving the vaccine9. This isn’t a slight statistical anomaly – it’s a consistent pattern suggesting our daughters bear the deadly burden of nonspecific effects.
Furthermore, across fifteen studies examining children who received DTP following BCG vaccination, mortality was 1.53 times higher in girls than boys9. These findings aren’t from fringe researchers but from meticulous studies published in respected medical journals. The pattern is unmistakable yet largely ignored by those entrusted with our children’s health.
List the culprits: Pentavalent, Hep B, H1N1, malaria, inactivated polio—all harm our girls!
DTP isn’t the lone threat to our daughters. A disturbing lineup of non-live vaccines shows the same deadly pattern. Research has identified six non-live vaccines associated with increased mortality in females10:
- Pentavalent vaccine (DTP plus hepatitis B and Haemophilus influenzae type B)
- Hepatitis B vaccine
- Inactivated polio vaccine
- H1N1 influenza vaccine
- RTS, S malaria vaccine
Each of these follows the same sinister template – disproportionately harming females through their nonspecific effects. This isn’t a coincidence; it’s a biological reality that vaccine manufacturers and global health agencies refuse to address.
The mechanism appears related to how non-live vaccines affect immune responses differently in males and females [26]. Unlike live vaccines that stimulate broad immune protection, non-live vaccines may suppress certain immune functions in female recipients, leaving them vulnerable to unrelated infections and diseases. This is the dark side of vaccination that mainstream science refuses to confront.
Flashback to ’92: WHO yanked high-titre measles for killing females, yet learned nothing!
The betrayal of our daughters isn’t new. Back in 1992, the World Health Organization (WHO) quietly withdrew its recommendation for a high-titer measles vaccine after discovering it was doubling female mortality compared to the standard measles vaccine10. The vaccine, introduced in 1989 for children under 9 months in high-risk areas, was pulled following alarming reports from Guinea-Bissau, Senegal, and Haiti11.
Multiple studies revealed this vaccine was specifically killing girls at alarming rates. The WHO had no choice but to rescind their recommendation – yet astonishingly, they failed to learn the broader lesson about sex-differential vaccine effects11. Instead of launching a comprehensive investigation into how vaccines might affect males and females differently, they treated it as an isolated incident and moved on.
Had independent researchers not assessed the effect of the high-titer measles vaccine on overall health, these “negative nonspecific and fatal effects” on females would likely have remained hidden10. This historical example provides a critical perspective – we must question whether current vaccines might have similar sex-specific effects that remain uninvestigated and unreported.
Rage against the machine: “This ain’t science—it’s a war on our future!”
The scientific establishment’s refusal to properly investigate and address these sex-differential effects is nothing short of criminal. In 2014, researchers demonstrated that most studies (7 of 10) suggested DTP has a deleterious impact, yet the literature was dismissed as “inconsistent” because two studies indicated a beneficial effect9. Above all, this selective interpretation of evidence reveals a system designed to maintain the status quo, not protect our children [21].
The World Health Organization’s Strategic Advisory Group of Experts (SAGE) review acknowledged that BCG and measles vaccines reduced mortality, yet it downplayed the troubling findings on DTP9 [22]. It concluded that there was “insufficient evidence of a differential between girls and boys” – a statement that flies in the face of the actual research.
Consequently, subsequent reviews have demonstrated that studies showing the beneficial effects of DTP had a high risk of survival and frailty bias12. Additional studies have consistently confirmed DTP’s adverse effects, which are “most marked for females, a pattern also seen for other non-live vaccines “12.
The evidence is clear: this isn’t about science but protecting a flawed system that refuses to acknowledge fundamental biological differences in vaccine responses. Our daughters deserve better than this deadly game of politics and profits over people.
Not only must we demand an immediate investigation into these sex-differential effects, but we also need complete transparency about what global health authorities have known and when they knew it. The lives of America’s daughters hang in the balance, and we can no longer trust those who have repeatedly betrayed that trust.
The Cover-Up: Globalists Bury the Truth
Image Source: NPR
Beyond shocking findings about vaccine effects lies an even darker truth: powerful global institutions have deliberately buried evidence that could save countless American lives. The systematic suppression of nonspecific effects research represents nothing less than a calculated betrayal of public trust.
Call out WHO’s 2014 dodge: Admitted NSEs, then sat on their hands!
In 2014, the World Health Organization finally acknowledged what independent researchers had been shouting for years—vaccines have powerful nonspecific effects far beyond their target diseases13. Their own Working Group confirmed that BCG and measles vaccines had a “beneficial effect on all-cause mortality in children “13. They even admitted that DTP’s effects “remain unclear “13.
Yet after this bombshell admission, what did the global health overlords do? Absolutely nothing! The Working Group shamefully concluded that “the evidence does not support a change in policy for DTP “13. This is despite reviewing studies showing that DTP had concerning effects in populations where the disease burden was low—precisely like today’s America!
Their report stated the glaring truth: “The findings… neither excludes nor confirms the possibility of beneficial or deleterious nonspecific immunological effects of vaccines on all cause-mortality “13. Translation: “We know these effects exist, but we’re choosing to ignore them!”
Moreover, the WHO did not just fail to act – they actively undermined future research by claiming there was “substantial heterogeneity of study designs “13. This excuse allowed them to dismiss mounting evidence showing DTP was harming our daughters. Subsequently, additional studies have repeatedly confirmed these adverse effects, predominantly affecting females – yet WHO policies remain frozen in place.
Slam Big Pharma’s one-size-fits-all scam: “They don’t care about American lives!”
Meanwhile, pharmaceutical giants have orchestrated a profit-driven scheme that puts Americans at risk. Big Pharma operates with a simple, sinister formula:
- Governments pump taxpayer money into vaccine development14
- Companies gain control of the products14
- Corporations lock up ownership and prioritize profits14
- Public health comes dead last14
Consider tuberculosis vaccines – despite potential use by tens of millions; they’re considered to have “no market “14 simply because they can’t generate the massive profits of products sold in wealthy nations. As Mike Frick of the Treatment Action Group bluntly stated: “We don’t ask for a fair deal from our pharma partners. We let them set the terms but don’t ask them to pick up the check “14.
This broken system “has for too long prioritized the needs of corporations over those of the sick and poor “14 [23]. The pharmaceutical industry’s one-size-fits-all approach isn’t about protecting American children but maximizing shareholder value regardless of who gets hurt!
Quote Plotkin’s Vaccines: “NSEs are real!”—even their own Bible betrays ’em!
Forthwith, the most damning evidence comes from vaccine promoters’ sacred text. Plotkin’s Vaccines – the definitive authority on immunization – now contains “all-new chapters on COVID-19, vaccine hesitancy, and nonspecific effects of vaccines “15. Yes, you read that correctly! The vaccine industry’s own Bible now admits NSEs are real!
This exhaustive medical reference clearly states these effects matter, detailing “up-to-date, authoritative information” on “the impact of vaccination programs on morbidity and mortality “15. If NSEs weren’t legitimate scientific phenomena, they wouldn’t merit inclusion in this authoritative text.
Furthermore, the book analyzes “the cost-benefit and cost-effectiveness of different vaccine options “15 – tacitly acknowledging what the globalist health apparatus won’t: different vaccines produce dramatically different outcomes beyond their target diseases.
This information in Plotkin’s work thoroughly exposes the hypocrisy of health authorities who publicly dismiss nonspecific effects while privately documenting their reality. This isn’t ignorance – it’s deliberate deception!
Tie it to RFK Jr.’s fight: He’s battling vaccine absolutism for our freedom!
Simultaneously, patriot Robert F. Kennedy Jr. stands on the frontlines battling vaccine absolutism, which threatens American health freedoms. Kennedy has repeatedly stated he wants to “improve the science on vaccine safety,” which he believes has “huge deficits” 16 [24]. Additionally, he champions informed choice, fighting for people to “make informed choices “16 rather than accept one-size-fits-all mandates.
His positions align perfectly with what nonspecific effects research shows – our current approach ignores critical science about how vaccines affect overall health. Kennedy’s critics label him “anti-vaccination” 17, yet his actual statements reflect exactly what NSE researchers have discovered – we need better science and tailored approaches.
The pharmaceutical establishment fears Kennedy precisely because he threatens their absolutist narrative. As Dr. David Elliman noted, RFK Jr. could “set back” vaccination programs16 – not because he opposes protection against disease, but because he demands accountability and scientific integrity.
The battle against globalist vaccine policies isn’t just academic – it’s about American sovereignty and our right to make health decisions based on complete information. The systematic burial of nonspecific effects research represents nothing less than medical tyranny – and patriots like Kennedy are leading the charge to uncover the truth!
COVID Vaccines: Heroes or Zeros?
Image Source: MDPI
The COVID-19 vaccine rollout revealed a shocking divide between vaccine types, fully confirming what we’ve uncovered about nonspecific effects. The data exposes a critical truth: not all COVID-19 vaccines are created equal, especially when examining their impact on overall mortality.
Drop the bomb: mRNA shots? Zero mortality benefit—31 vs. 30 deaths in trials!
First, let’s face the cold, hard facts that Big Pharma wants to be buried. The two major randomized controlled trials of mRNA vaccines (Pfizer and Moderna) included 74,193 adults, with 37,110 receiving vaccines and 37,083 getting placebo18. The shocking truth? These trials recorded 61 total deaths – 31 in the vaccinated group versus 30 in the placebo group18. That’s a relative risk of 1.03 (95% CI: 0.63-1.71) for overall mortality18!
Patriots, this means mRNA shots provided zero benefit in reducing all-cause mortality in their clinical trials! The establishment pushed these experimental technologies on Americans without proof they saved lives overall. Indeed, the prosecution suggested a lower COVID-19 death risk (RR = 0.40), yet this wasn’t even statistically significant18. In essence, these globalist-backed technologies failed the most crucial test: reducing total deaths.
Contrast adenovirus shots: 37% less death, a spark of hope!
In contrast, adenovirus-vector vaccines like Johnson & Johnson showed genuinely promising results. These vaccines were associated with a statistically significant 63% reduction in overall mortality (RR = 0.37, 95% CI: 0.19-0.70)18. This remarkable difference came primarily from lower COVID-19 mortality and, notably, lower cardiovascular deaths (0 vs. five deaths)18.
The pattern is unmistakable and internally consistent within trials:
- mRNA technology: No reduction in all-cause mortality
- Adenovirus technology: Significant reduction in overall deaths
This dramatic contrast represents “obvious public health importance” 18. Henceforth, if verified in future studies, the protective nonspecific effects of adenovirus vaccines could offer vital advantages for vulnerable Americans with high cardiovascular risk18.
Demand accountability: “Why no all-cause mortality studies? What’re they hiding?”
Considering this evidence, why aren’t health authorities demanding comprehensive all-cause mortality studies for all COVID-19 vaccines? A 2024 analysis of UK data found that across all age groups, all-cause mortality standardized mortality ratios (SMRs) initially appeared lower in vaccinated people but increased over time19. Chiefly, for specific age groups, these ratios eventually exceeded reference values19.
What’s even more concerning? The study authors noted it’s “implausible that COVID-19 vaccines protect against non-COVID-19 deaths,” suggesting significant biases in the dataset that underestimate risks for vaccinated individuals19. Thus, the current data may mask potential harms!
As a result, researchers call for something essential: “other significant countries to collect all-cause mortality by vaccination status “19 systematically. Why isn’t this happening already? What are they afraid we’ll find?
Push for truth: America deserves vaccines that work, not globalist experiments!
America deserves vaccines that save lives – not just against one disease, but overall. The marked differences between mRNA and adenovirus vaccines demand immediate investigation and policy changes.
Likewise, we need personalized approaches that acknowledge nonspecific effects. The one-size-fits-all globalist approach isn’t working! Preliminary evidence from Norway shows that vaccinated individuals had lower all-cause mortality rates between 2021 and 2023, yet these findings conflict with UK data, which shows increasing mortality ratios over time19.
In the meantime, Americans deserve complete transparency about what we know – and don’t know. Each citizen can examine unbiased all-cause mortality data when making vaccination decisions. The future of American health freedom depends on breaking the stranglehold of pharmaceutical interests and demanding vaccines that improve overall survival.
Patriots, the battle line is drawn: Will we accept products with zero mortality benefits or demand better? The fight for vaccine truth is the fight for America’s health sovereignty!
The Fix: Smarter Policies for a Stronger America
Image Source: Peterson Foundation
America needs a battle plan to fix our broken vaccine policies! The scientific evidence demands immediate action to protect our children from harmful, nonspecific effects while maximizing benefits. With proper implementation, we can transform our nation’s health using what we know about how vaccines work.
Lay out Benn’s plan: BCG at birth, live vaccines first, no DTP after measles!
Dr. Christine Stabell Benn’s revolutionary research provides a clear roadmap for protecting American children. The first things to remember about her evidence-based protocol:
- Administer BCG vaccine immediately after birth to maximize its powerful 48% reduction in neonatal mortality1
- Prioritize live vaccines early in the schedule to establish beneficial trained immunity
- Never give DTP after the measles vaccine, as this sequence destroys measles’ protective effects
- Open BCG multi-dose vials even for a single infant—the benefits far outweigh any waste concerns
Unquestionably, this sequence matters! The current schedule ignores these critical interactions between vaccines. Benn’s approach isn’t theoretical—it’s backed by complex data showing dramatic reductions in all-cause mortality. Most compelling, her protocol could save thousands of American lives annually without developing a single new vaccine.
Stress strains: BCG-Denmark saves, BCG-Russia flops—choose right!
Not all BCG vaccines are created equal! BCG-Danish consistently produces excellent results with scar rates exceeding 90%, whereas BCG-Moscow achieves only 52% scar formation1. This isn’t just a cosmetic difference—scar formation directly correlates with more substantial nonspecific benefits and excellent protection.
In the same fashion, guinea pig studies show significant variability between strains. Though BCG Tice demonstrated slightly better efficacy than some strains, with ≤0.2 log fewer tuberculosis bacteria in lungs and spleens3, the real-world performance differences are stark. BCG-Denmark reduced neonatal mortality by 48% in randomized trials1, making strain selection critically important.
Truth is, America deserves only the best! Our children shouldn’t receive inferior strains when better options exist. Accordingly, national policy must specify “BCG vaccination” and precisely which strain delivers optimal protection.
Call for reform: “One-size-fits-all is tyranny! Tailor vaccines for our kids!”
The globalist approach of identical vaccines for everyone ignores fundamental biological realities! Genetic factors, prior infections, and environmental exposures—create different immune responses across populations2. One-size-fits-all isn’t science—it’s a lazy policy that sacrifices our children’s health!
Studies demonstrate substantial variability in BCG’s effectiveness across different populations2. Furthermore, research shows that other vaccines have drastically different effects based on sex, age, and sequence of administration. Analogous to how we’d never give the exact medication dosage to all patients regardless of weight, age, or condition, our vaccine policies must recognize these critical differences.
As opposed to the current system, America needs personalized vaccination approaches that acknowledge the following:
- Different vaccine strains produce different outcomes
- Vaccine sequence substantially impacts overall mortality
- Sex-differentiated responses require tailored protocols
- Timing of administration dramatically affects the protection
The vision of Victory: Lower mortality, healthier kids, and a mighty USA!
Imagine an America where innovative vaccine policies slash infant mortality rates by nearly half! By implementing Benn’s recommendations, we could substantially improve protection against tuberculosis while simultaneously reducing deaths from numerous other causes1.
Given these facts, our path forward is clear: manufacture standardized BCG from a single genotype, compare different strains head-to-head to identify optimal protection, investigate revaccination benefits, and ensure administration within days of birth1.
To this end, we need patriots demanding accountability from health authorities. Our children’s immunity shouldn’t be compromised by outdated policies that ignore nonspecific effects! Proper strain selection and vaccine sequencing can build stronger natural immunity in our population while avoiding harmful nonspecific effects.
The victory is within reach—healthier American children with robust immune systems, dramatically lower infant mortality rates, and a nation protected from target diseases and all-cause mortality. The science is precise; we need the courage to implement it and make America healthy again!
Conclusion: Patriots, Rise!
Science speaks the truth – BCG stands as America’s shield while non-live vaccines threaten our daughters’ lives. Raw data proves BCG slashes infant mortality rates by 38%, creates broad protection against multiple diseases, and strengthens our children’s natural immunity. Meanwhile, DTP doubled death rates for girls, yet global health authorities refuse to act.
Patriots across America must face these hard facts: WHO acknowledged nonspecific effects in 2014, then betrayed public trust through inaction. Big Pharma pushes its one-size-fits-all agenda while burying evidence that could save countless American lives. Its own Bible—Plotkin’s Vaccines—admits these effects exist, though it publicly denies the truth.
Dr. Christine Stabell Benn’s research lights our path forward. BCG at birth, live vaccines first, careful scheduling – these simple changes could dramatically reduce American infant mortality. Danish strain BCG outperforms Russian versions, proving strain selection matters when protecting our nation’s future.
Patriots, Rise and Fight for America’s Health and Freedom! BCG’s saving our kids while DTP spikes mortality for our daughters—2.54 times higher! Christine Stabell Benn exposed their game, RFK Jr. fights the elites, and now we must flood Congress with demands for BCG at birth, share this truth with every American, and support leaders battling vaccine absolutism!
America deserves better than globalist experiments and pharmaceutical profits over people. Together, we will demand innovative vaccine policies that acknowledge nonspecific effects, protect our daughters, and strengthen our nation’s health. This fight belongs to every American who believes in truth, freedom, and our children’s right to proper protection. Let’s make America healthy again – our future depends on it!
Legal Disclaimer and Warning
Pay attention, fellow patriots! As we battle for health freedom, I must clarify one thing about this article: educational information, not medical advice. Federal law requires healthcare providers to give you Vaccine Information Statements (VIS) before certain vaccinations4. Nevertheless, I’m giving you the raw truth about the Nonspecific Effects of Vaccines so you can make informed decisions.
Folks, I’m giving you the raw truth, but listen close! This article ain’t medical advice—it’s a wake-up call to dig into the science and fight for what’s right! Vaccines are serious business, and while we’re exposing the nonspecific effects of cover-up, you gotta talk to a trusted doctor before making any health choices for you or your family. The info here comes from real studies like Christine Stabell Benn’s and Plotkin’s Vaccines, but it’s for education, not prescription! We’re battling for America’s health and freedom, not telling you to skip shots—that’s your call, patriots! Always check primary sources and question everything ’cause the globalists hate it when we think for ourselves!
For transparency, understand that your right to choose whether to vaccinate remains a cornerstone of health freedom. Belief in freedom of choice was a major predictor of COVID-19 vaccine acceptance in studies5. At the same time, VISs must be provided before every dose of specific vaccines covered under the National Childhood Vaccine Injury Act.
Given these facts, I urge you to exercise your Child Health Sovereignty! The law requires healthcare providers to record specific information in their medical records, including the edition date of the VIS and the date it was provided4. Be vigilant about this documentation as you fight against Vaccine Safety Lies!
In addition, vaccines have unquestionably saved 4-5 million lives yearly worldwide6. Yet, I’m primarily fighting to expose what Plotkin’s Vaccines Proof acknowledges—that Nonspecific Effects are real!
With this in mind, talk to healthcare providers you trust. Research shows diverse opinions about vaccines7, and it’s your right to question absolutist positions. Respect for valid health and religious exemptions is essential.
Stand tall, patriots! Demand truth! This battle for America’s health freedom doesn’t mean rejecting all vaccines – it means demanding better ones and proper sequences! Question everything, and remember: the globalists tremble when Americans think for themselves!
References
[1] – https://pmc.ncbi.nlm.nih.gov/articles/PMC4551012/
[2] – https://www.sciencedirect.com/science/article/pii/S2950194624001973
[3] – https://pmc.ncbi.nlm.nih.gov/articles/PMC2657049/
[4] – https://www.cdc.gov/vaccines/hcp/vis/about/facts-vis.html
[5] – https://pmc.ncbi.nlm.nih.gov/articles/PMC9693986/
[6] – https://www.sciencedirect.com/science/article/abs/pii/S0264410X23009489
[7] – https://pmc.ncbi.nlm.nih.gov/articles/PMC10070776/
[8] – https://pmc.ncbi.nlm.nih.gov/articles/PMC9358328/
[9] – https://pmc.ncbi.nlm.nih.gov/articles/PMC5155548/
[10] – https://pmc.ncbi.nlm.nih.gov/articles/PMC10116894/
[11] – https://pubmed.ncbi.nlm.nih.gov/12913835/
[12] – https://www.sciencedirect.com/science/article/abs/pii/S0264410X21007209
[15] – https://www.sciencedirect.com/book/9780323790581/plotkins-vaccines
[16] – https://www.bbc.com/news/articles/c0mzk2y41zvo
[18] – https://pmc.ncbi.nlm.nih.gov/articles/PMC10125209/
[19] – https://pubmed.ncbi.nlm.nih.gov/40028449/
[20] – https://www.medrxiv.org/content/10.1101/2024.12.15.24319058v1
[21] – Gad-el-Hak, M. (2015). To Mooc, Or Not To Mooc, That Is The Question. Mechanical Engineering, 137(9), 46-47.
[22] – Cancer, A., Cancer, A., Salvi, C., Antonietti, A., & Iannello, P. (2023). Not Getting Vaccinated? It Is a Matter of Problem-Solving Abilities and Socio-Cognitive Polarization—International Journal of Environmental Research and Public Health, 20(3), 1721.
[23] – How Pharma Giant GSK Stalled a Potentially Lifesaving Tuberculosis Vaccine in Pursuit of Bigger Profits – Factkeepers.com. https://factkeepers.com/how-pharma-giant-gsk-stalled-a-potentially-lifesaving-tuberculosis-vaccine-in-pursuit-of-bigger-profits/
[24] – Fact-checking his views on health policy | Areatatafo. https://areatatafo.com.ng/fact-checking-his-views-on-health-policy/
[25] – (2024). APEC Workshop on Promoting Energy Efficiency in the Manufacturing Sector. MENA Report, (),.
[26] – Navarro, F., & WatkinsStephanie, K. (2017). Estrogen Stimulation Differentially Impacts Human Male and Female Antigen-Specific T Cell Anti-Tumor Function and Polyfunctionality. Gender and the Genome. https://doi.org/10.1089/gg.2017.0014
[27] – https://www.infowars.com/posts/the-hidden-effects-of-vaccines
[28] – https://brownstone.org/articles/the-hidden-effects-of-vaccines/
[29] – https://www.sciencedirect.com/science/article/pii/S0264410X25001811?via%3Dihub
[30] – https://www.sciencedirect.com/science/article/abs/pii/S0264410X25001811?via%3Dihub
[31] – P. Aaby et al. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy Lancet (1988)
[32] – S. Prentice et al. BCG-induced nonspecific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomized controlled trial Lancet Infect Dis (2021)
[33] – D.L. Faustman et al. Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes Cell Rep Med (2022)
[34] – C.S. Benn et al. Vaccinology: time to change the paradigm? Lancet Infect Dis (2020)
[35] – C.S. Benn et al. Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial nonspecific effects? iScience (2023)
[36] – P. Aaby et al. Differences in female-male mortality after high-titer measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of west African studies Lancet (2003)
[37] – A. Angelidou et al. Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content, and innate immune activation Vaccine (2020)
[38] – C.S. Benn et al. Revaccination with live attenuated vaccines confer additional beneficial nonspecific effects on overall survival: a review EBioMedicine (2016)
[39] – P. Aaby et al. Beneficial nonspecific effects of live vaccines against COVID-19 and other unrelated infections Lancet Infect Dis (2023)
[40] – S. Nielsen et al. Effect of early two-dose measles vaccination on childhood mortality and modification by maternal measles antibody in Guinea-Bissau, West Africa: a single-center open-label randomized controlled trial EClinicalMedicine (2022)
[41] – P. Aaby et al. Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations may reduce infant mortality more than the WHO schedule of BCG first and then DTP. A reanalysis of demographic surveillance data from rural Bangladesh EBioMedicine(2017)
[42] – P. Aaby et al. Nonspecific beneficial effect of measles immunization: analysis of mortality studies from developing countries BMJ (1995)
[43] – P. Aaby et al. Sex-specific differences in mortality after high-titre measles immunization in rural Senegal Bull World Health Organ (1994)
[44] – E.A. Holt et al. Differential mortality by measles vaccine titer and sex J Infect Dis (1993)
[45] – WHO, Immunization EPo. Consultation on studies involving high titer of measles vaccines Wkly Epidemiol Rec (1992)
[46] – S. Biering-Sorensen et al. Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial Clin Infect Dis (2017)
[47] – S.M. Thysen et al. Can earlier BCG-Japan and OPV vaccinations reduce early infant mortality? A cluster-randomised trial in Guinea-Bissau BMJ Glob Health (2024)
[48] – https://pubmed.ncbi.nlm.nih.gov/37437155/
[49] – https://pubmed.ncbi.nlm.nih.gov/37099341/
[50] – https://pubmed.ncbi.nlm.nih.gov/37437154/
[51] – https://pubmed.ncbi.nlm.nih.gov/37437156/
[52] – https://pubmed.ncbi.nlm.nih.gov/35920693/
[53] – https://pubmed.ncbi.nlm.nih.gov/34131332/
[54] – Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomized controlled phase 3 trial. Pittet LF, Messina NL, McDonald E, Orsini F, Barry S, Bonten M, Campbell J, Croda J, Croda MG, Dalcolmo M, Gardiner K, Gwee A, Jardim B, Lacerda MVG, Lucas M, Lynn DJ, Manning L, Perrett KP, Post JJ, Prat-Aymerich C, Richmond PC, Rocha JL, Rodriguez-Baño J, Warris A, Wood NJ, Davidson A, Curtis N; BRACE Trial Consortium Group. EClinicalMedicine. 2024 May 13;72:102616. Doi: 10.1016/j.eclinm.2024.102616. eCollection 2024 Jun. PMID: 38774675
[55] – The mark of success: The role of vaccine-induced skin scar formation for BCG and smallpox vaccine-associated clinical benefits. Bæk O, Schaltz-Buchholzer F, Campbell A, Amenyogbe N, Campbell J, Aaby P, Benn CS, Kollmann TR. Semin Immunopathol. 2024 Aug 26;46(5):13. doi: 10.1007/s00281-024-01022-9. PMID: 39186134
[56] – BCG vaccination is associated with longitudinal changes in systemic eicosanoid levels in elderly individuals: A secondary outcome analysis. Nathella PK, Padmapriyadarsini C, Nancy A, Karunanithi K, Selvaraj N, Renji RM, Shrinivasa BM, Babu S. Heliyon. 2024 June 11;10(12):e32643. doi: 10.1016/j.heliyon.2024.e32643. eCollection 2024 June 30. PMID: 38975122
[57] – https://www.sciencedirect.com/science/article/abs/pii/S147330991930742X
[58] – https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/retinol
[59] – https://www.sciencedirect.com/topics/medicine-and-dentistry/mycobacterium-bovis-bcg
[61] – https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/measles
[62] – https://www.sciencedirect.com/topics/medicine-and-dentistry/vaccination-coverage
[63] – https://www.sciencedirect.com/topics/medicine-and-dentistry/diphtheria
[64] – https://www.sciencedirect.com/topics/medicine-and-dentistry/tetanus
[67] – P Aaby et al. Measles vaccination and child mortality Lancet (1981)
[68] – P Aaby et al. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy Lancet (1988)
[69] – P Aaby et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies Lancet (2003)
[70] – CS Benn et al. Campaigns with oral polio vaccine may lower mortality and create unexpected results Vaccine (2017)
[71] – A Schoeps et al. No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial Vaccine (2018)
[72] – P Welaga et al. Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana Vaccine (2017)
[73] – E Seppälä et al. Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media Vaccine (2011)
[74] – P Aaby et al. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau Vaccine (2006)
[75] – CS Benn et al. Revaccination with live attenuated vaccines confer additional beneficial nonspecific effects on overall survival: a review EBioMedicine (2016)
[76] – S Byberg et al. A general measles vaccination campaign in urban Guinea-Bissau: comparing child mortality among participants and non-participants Vaccine (2017)
[77] – SW Mogensen et al. The introduction of diphtheria-tetanus-pertussis and oral polio vaccine among young infants in an urban African community: a natural experiment EBioMedicine (2017)
[78] – P Aaby et al. RTS, S/AS01 malaria vaccine and child mortality Lancet (2015)
[79] – AB Fisker et al. Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau Vaccine (2016)
[80] – AB Fisker et al. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study Lancet Glob Health (2014)
[81] – AB Fisker et al. Non-live pentavalent vaccines after live measles vaccine may increase mortality Vaccine (2018)
[82] – S Hirve et al. Nonspecific and sex-differential effects of vaccinations on child survival in rural western India Vaccine (2012)
[83] – P Aaby et al. Co-administration of BCG and diphtheria-tetanus-pertussis (DTP) vaccinations may reduce infant mortality more than the WHO schedule of BCG first and then DTP. A reanalysis of demographic surveillance data from rural Bangladesh EBioMedicine (2017)
[84] – S Sørup et al. Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register-based cohort study Vaccine (2016)
[85] – DA Ross Vitamin A and childhood mortality Lancet (1993)
[86] – CS Benn et al. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana Vitamin A Supplementation Trial Am J Clin Nutr (2009)
[87] – CS Benn et al. The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination Vaccine (2009)
[88] – CS Benn et al. Interaction between neonatal vitamin A supplementation and timing of measles vaccination: a retrospective analysis of three randomized trials from Guinea-Bissau Vaccine (2014)
[89] – S Sørup et al. Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact Vaccine (2015)
[90] – EN Fish et al. Changing the oral vaccine to an inactivated polio vaccine might increase mortality Lancet (2016)
[91] – P Aaby et al. Stopping live vaccines after disease eradication may increase mortality Vaccine (2020)
[92] – RJW Arts et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity Cell Host Microbe (2018)
[93] – P Aaby et al. Oral polio vaccination and low case fatality at the pediatric ward in Bissau, Guinea-Bissau Vaccine (2004)
[94] – B Greenwood The contribution of vaccination to global health: past, present and future Philos Trans R Soc Lond B Biol Sci (2014)
[95] – A Mayr Taking advantage of the positive side-effects of smallpox vaccination J Vet Med B Infect Dis Vet Public Health (2004)
[96] – A Calmette Preventive vaccination against tuberculosis with BCG Proc R Soc Med (1931)
[97] – EU Vaccination glossary WHO recommendations for routine immunization – summary tables: interrupted and delayed vaccination T Kuhn The structure of scientific revolutions (1962)
[98] – P Aaby et al. The optimal age of measles immunization in low-income countries: a secondary analysis of the assumptions underlying the current policy BMJ Open (2012)
[99] – Influence of measles vaccination on survival pattern of 7–35-month-old children in Kasongo, Zaire Lancet (1981)
[100] – MA Koenig et al. Impact of measles vaccination on childhood mortality in rural Bangladesh Bull World Health Organ (1990)
[101] – EA Holt et al. Childhood survival in Haiti: protective effect of measles vaccination Pediatrics (1990)
[102] – P Aaby et al. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency: an unplanned study Pediatr Infect Dis J (2003)
[103] – P Aaby et al. Nonspecific effects of standard measles vaccine at 4·5 and 9 months of age on childhood mortality: randomized controlled trial BMJ (2010)
[104] – MJ Mina et al. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality Science (2015)
[105] – CS Benn et al. How to evaluate potential nonspecific effects of vaccines: the quest for randomized trials or time for triangulation? Expert Rev Vaccines (2018)
[106] – S Sørup et al. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections JAMA (2014)
[107] – G La Torre et al. The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: a retrospective cohort study Hum Vaccin Immunother (2017)
[108] – SMAJ Tielemans et al. Nonspecific effects of measles, mumps, and rubella (MMR) vaccination in high-income setting: population based cohort study in the Netherlands BMJ (2017)
[109] – BH Bardenheier et al. Risk of nontargeted infectious disease hospitalizations among US children following inactivated and live vaccines, 2005–2014 Clin Infect Dis (2017)
[110] – CS Benn et al. Beneficial nonspecific reduction in hospital admissions for respiratory infections following MMR and MenC vaccinations in the Netherlands BMJ (2017)
[111] – EA Holt et al. Differential mortality by measles vaccine titer and sex J Infect Dis (1993)
[112] – Consultation on studies involving high titer of measles vaccines Wkly Epidemiol Rec (1992)
[113] – I Kristensen et al. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa BMJ (2000)
[114] – S Biering-Sørensen et al. Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial Clin Infect Dis (2017)
[115] – https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30742-X/abstract
[116] -Greenwood, B
The contribution of vaccination to global health: past, present and future
Philos Trans R Soc Lond B Biol Sci. 2014; 369, 20130433
[117] – Mayr, A
Taking advantage of the positive side-effects of smallpox vaccination
J Vet Med B Infect Dis Vet Public Health. 2004; 51:199-201
[118] – Calmette, A
Preventive vaccination against tuberculosis with BCG
Proc R Soc Med. 1931; 24:1481-1490
[119] – EU Vaccination glossary
Date: 2018
Date accessed: November 5, 2019
[120] – WHO
WHO recommendations for routine immunization – summary tables: interrupted and delayed vaccination
Date: 2019
Date accessed: November 5, 2019
[121] – Kuhn, T
The structure of scientific revolutions
University of Chicago Press, Chicago, 1962
[122] – Aaby, P ∙ Martins, CL ∙ Garly, ML ∙ et al.
The Optimal Age of Measles Immunization in low-income Countries: A Secondary Analysis of the Assumptions Underlying the Current Policy
BMJ Open. 2012; 2, e000761
[123] – The Kasongo Project Team
Influence of measles vaccination on survival pattern of 7–35-month-old children in Kasongo, Zaire
Lancet. 1981; 317:764-767
[124] – Koenig, MA ∙ Khan, MA ∙ Wojtyniak, B ∙ et al.
Impact of measles vaccination on childhood mortality in rural Bangladesh
Bull World Health Organ. 1990; 68:441-447
[125] – Holt, EA ∙ Boulos, R ∙ Halsey, NA ∙ et al.
Childhood survival in Haiti: protective effect of measles vaccination
Pediatrics. 1990; 85:188-194
[126] – Aaby, P ∙ Bukh, J ∙ Lisse, IM ∙ et al.
Measles vaccination and child mortality
Lancet. 1981; 2:93
[127] – Aaby, P ∙ Garly, ML ∙ Balé, C ∙ et al.
Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency: an unplanned study
Pediatr Infect Dis J. 2003; 22:798-805
[128] – Aaby, P ∙ Martins, CL ∙ Garly, ML ∙ et al.
Nonspecific effects of standard measles vaccine at 4·5 and 9 months of age on childhood mortality: randomized controlled trial
BMJ. 2010; 341, c6495
[129] – Mina, MJ ∙ Metcalf, CJ ∙ de Swart, RL ∙ et al.
Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.
Science. 2015; 348:694-699
[130] – Benn, CS ∙ Fisker, AB ∙ Rieckmann, A ∙ et al.
How to evaluate potential nonspecific effects of vaccines: the quest for randomized trials or time for triangulation?
Expert Rev Vaccines. 2018; 17:411-420
[131] – Sørup, S ∙ Benn, CS ∙ Poulsen, A ∙ et al.
Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections
JAMA. 2014; 311:826-835
[132] – La Torre, G ∙ Saulle, R ∙ Unim, B ∙ et al.
The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: a retrospective cohort study
Hum Vaccin Immunother. 2017; 13:1879-1883
[133] –
Tielemans, SMAJ ∙ de Melker, HE ∙ Hahné, SJM ∙ et al.
Nonspecific effects of measles, mumps, and rubella (MMR) vaccination in high-income setting: population-based cohort study in the Netherlands
BMJ. 2017; 358, j3862
[134] – Bardenheier, BH ∙ McNeil, MM ∙ Wodi, AP ∙ et al.
Risk of nontargeted infectious disease hospitalizations among US children following inactivated and live vaccines, 2005–2014
Clin Infect Dis. 2017; 65:729-737
[135] – Benn, CS ∙ Sørup, S ∙ Aaby, P
Beneficial nonspecific reduction in hospital admissions for respiratory infections following MMR and MenC vaccinations in the Netherlands
BMJ. 2017; 358, j3862
[136] – Aaby, P ∙ Jensen, TG ∙ Hansen, HL ∙ et al.
Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy
Lancet. 1988; 2:809-811
[137] – Aaby, P ∙ Jensen, H ∙ Samb, B ∙ et al.
Differences in female-male mortality after high-titer measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies
Lancet. 2003; 361:2183-2188
[138] – Holt, EA ∙ Moulton, LH ∙ Siberry, GK ∙ et al.
Differential mortality by measles vaccine titer and sex
J Infect Dis. 1993; 168:1087-1096
[139] – World Health Organization
Consultation on studies involving high titer of measles vaccines
Wkly Epidemiol Rec. 1992; 67:357-361
[140] – Kristensen, I ∙ Aaby, P ∙ Jensen, H ∙ et al.
Routine vaccinations and child survival: follow-up study in Guinea-Bissau, West Africa
BMJ. 2000; 321:1435-1438
[141] – Biering-Sørensen, S ∙ Aaby, P ∙ Lund, N ∙ et al.
Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial
Clin Infect Dis. 2017; 65:1183-1190
[142] – Jayaraman, K ∙ Adhisivam, B ∙ Nallasivan, S ∙ et al.
Two randomized trials of the effect of the Russian strain of bacillus Calmette-Guérin alone or with oral polio vaccine on neonatal mortality in infants weighing <2000 g in India
Pediatr Infect Dis J. 2019; 38:198-202
[143] – Roth, AE ∙ Benn, CS ∙ Ravn, H ∙ et al.
Effect of revaccination with BCG in early childhood on mortality: randomized trial in Guinea-Bissau
BMJ. 2010; 340:c671
[144] – Lund, N ∙ Andersen, A ∙ Hansen, AS ∙ et al.
The effect of oral polio vaccine at birth on infant mortality: a randomized trial
Clin Infect Dis. 2015; 61:1504-1511
[145] – Aaby, P ∙ Ravn, H ∙ Benn, CS ∙ et al.
Randomized trials comparing inactivated vaccine after medium- or high-titer measles vaccine with standard titer measles vaccine after inactivated vaccine: a meta-analysis
Pediatr Infect Dis J. 2016; 35:1232-1241
[146] – Fisker, AB ∙ Nebie, E ∙ Schoeps, A ∙ et al.
A two-center randomized trial of an additional early dose of measles vaccine: effects on mortality and measles antibody levels
Clin Infect Dis. 2018; 66:1573-1580
[147] – Stensballe, LG ∙ Ravn, H ∙ Birk, NM ∙ et al.
BCG vaccination at birth and rate of hospitalization for infection until 15 months of age in Danish children: a randomized clinical multicenter trial
J Pediatric Infect Dis Soc. 2019; 8:213-220
[148] – Benn, CS ∙ Jacobsen, LH ∙ Fisker, AB ∙ et al.
Campaigns with oral polio vaccine may lower mortality and create unexpected results.
Vaccine. 2017; 35:1113-1116
[149] – Andersen, A ∙ Fisker, AB ∙ Rodrigues, A ∙ et al.
National immunization campaigns with oral polio vaccine reduce all-cause mortality: a natural experiment within seven randomized trials.
Front Public Health. 2018; 6:13
[150] – Schoeps, A ∙ Nebié, E ∙ Fisker, AB ∙ et al.
No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial
Vaccine. 2018; 36:1965-1971
[151] – Welaga, P ∙ Oduro, A ∙ Debpuur, C ∙ et al.
Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana
Vaccine. 2017; 35:2496-2503
[152] – Sørup, S ∙ Stensballe, LG ∙ Krause, TG ∙ et al.
Oral polio vaccination and hospital admissions with non-polio infections in Denmark: a nationwide retrospective cohort study
Open Forum Infect Dis. 2015; 3, ofv204
[153] – Upfill-Brown, A ∙ Taniuchi, M ∙ Platts-Mills, JA ∙ et al.
Nonspecific effects of oral polio vaccine on diarrheal burden and etiology among Bangladeshi infants
Clin Infect Dis. 2017; 65:414-419
[154] – Seppälä, E ∙ Viskari, H ∙ Hoppu, S ∙ et al.
Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media
Vaccine. 2011; 29:8615-8618
[155] – WHO
Immunization, Vaccines and Biologicals
Date: 2013
Date accessed: February 10, 2020
[156] – Aaby, P ∙ Gustafson, P ∙ Roth, A ∙ et al.
Vaccinia scars are associated with better survival for adults. An observational study from Guinea-Bissau
Vaccine. 2006; 24:5718-5725
[157] – Rieckmann, A ∙ Villumsen, M ∙ Sørup, S ∙ et al.
Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971–2010
Int J Epidemiol. 2017; 46:695-705
[158] – WHO
Expanded program on immunization. The optimal age for measles immunization
Wkly Epidemiol Rec. 1982; 57:89-91
[159] – Meeting of the Immunization Strategic Advisory Group of Experts, November 2006—conclusions and recommendations
Wkly Epidemiol Rec. 2007; 82:1-16
[160] – Aaby, P ∙ Martins, CL ∙ Ravn, H ∙ et al.
Is early measles vaccination better than later measles vaccination?
Trans R Soc Trop Med Hyg. 2015; 109:16-28
[161] – Benn, CS ∙ Martins, CL ∙ Andersen, A ∙ et al.
Measles vaccination in the presence of measles antibodies may enhance child survival.
FrontPediatr. 2020; published online February 7.
[162] – Aaby, P ∙ Martins, CL ∙ Garly, ML ∙ et al.
Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival
Clin Infect Dis. 2014; 59:484-492
[163] – Fisker, AB ∙ Rodrigues, A ∙ Martins, C ∙ et al.
Reduced all-cause child mortality after general measles vaccination campaign in rural Guinea-Bissau
Pediatr Infect Dis J. 2015; 34:1369-1376
[164] – Benn, CS ∙ Fisker, AB ∙ Whittle, HC ∙ et al.
Revaccination with live attenuated vaccines confer additional beneficial nonspecific effects on overall survival: a review.
EBioMedicine. 2016; 10:312-317
[165] – Byberg, S ∙ Thysen, SM ∙ Rodrigues, A ∙ et al.
A general measles vaccination campaign in urban Guinea-Bissau: comparing child mortality among participants and non-participants
Vaccine. 2017; 35:33-39
[166] – Welaga, P ∙ Hodgson, A ∙ Debpuur, C ∙ et al.
Measles vaccination supports Millennium Development Goal 4: increasing coverage and increasing child survival in northern Ghana, 1996–2012
Front Public Health. 2018; 6:28
[167] – Sergent, E
Premunition antituberculose par le BCG. Campagne poursuive depuis 1935 sur 21,244 nouveau-nes vaccines et 20,063 non vaccines: premiere note
Arch Inst Pasteur Alger. 1954; 32:1-8
[168] – Sørup, S ∙ Jensen, AKG ∙ Aaby, P ∙ et al.
Revaccination with measles-mumps-rubella vaccine and infectious disease morbidity: a Danish register-based cohort study
Clin Infect Dis. 2019; 68:282-290
[169] – Mogensen, SW ∙ Andersen, A ∙ Rodrigues, A ∙ et al.
The introduction of diphtheria-tetanus-pertussis and oral polio vaccine among young infants in an urban African community: a natural experiment
EBioMedicine. 2017; 17:192-198
[170] – Aaby, P ∙ Mogensen, SW ∙ Rodrigues, A ∙ et al.
Evidence of an increase in mortality after the introduction of the diphtheria-tetanus-pertussis vaccine to children aged 6–35 months in Guinea-Bissau: a time for reflection?
Front Public Health. 2018; 6:79
[171] – Aaby, P ∙ Jensen, H ∙ Gomes, J ∙ et al.
The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study
Int J Epidemiol. 2004; 33:374-380
[172] – Aaby, P ∙ Ravn, H ∙ Benn, CS
The WHO review of the possible nonspecific effects of the diphtheria-tetanus-pertussis vaccine
Pediatr Infect Dis J. 2016; 35:1247-1257
[173] – Aaby, P ∙ Ravn, H ∙ Fisker, AB ∙ et al.
Is diphtheria-tetanus-pertussis (DTP) associated with increased female mortality? A meta-analysis testing the hypotheses of sex-differential nonspecific effects of DTP vaccine
Trans R Soc Trop Med Hyg. 2016; 110:570-581
[174] – RTS, S Clinical Trials Partnership
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of phase 3, individually randomized, controlled trial
Lancet. 2015; 386:31-45
[175] – Aaby, P ∙ Rodrigues, A ∙ Kofoed, PE ∙ et al.
RTS, S/AS01 malaria vaccine and child mortality
Lancet. 2015; 386:1735-1736
[176] – Klein, SL ∙ Shann, F ∙ Moss, WJ ∙ et al.
RTS, S Malaria Vaccine and Increased Mortality in Girls
MBio. 2016; 7:e00514-e00516
[177] – Aaby, P ∙ Garly, ML ∙ Nielsen, J ∙ et al.
Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau
Pediatr Infect Dis J. 2007; 26:247-252
[178] – Garly, ML ∙ Jensen, H ∙ Martins, CL ∙ et al.
Hepatitis B vaccination associated with higher female than male mortality in Guinea-Bissau: an observational study
Pediatr Infect Dis J. 2004; 23:1086-1092
[179] – Fisker, AB ∙ Biering-Sørensen, S ∙ Lund, N ∙ et al.
Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau
Vaccine. 2016; 34:4551-4557
[180] – Hanifi, SMA
Nonspecific Effects of Vaccines and sex-differential Child Mortality in Rural Bangladesh
PhD thesis University of Southern Denmark, 2018
[181] – Aaby, P ∙ Benn, C ∙ Nielsen, J ∙ et al.
Testing the hypothesis that the diphtheria-tetanus-pertussis vaccine has adverse nonspecific and sex-differential effects on child survival in high-mortality countries
BMJ Open. 2012; 2, e000707
[182] – Kagoné, M ∙ Yé, M ∙ Nébié, E ∙ et al.
Vaccination coverage and factors associated with adherence to the vaccination schedule in young children of a rural area in Burkina Faso
Glob Health Action. 2017; 10, 1399749
[183] – Fisker, AB ∙ Hornshøj, L ∙ Rodrigues, A ∙ et al.
Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study
Lancet Glob Health. 2014; 2:e478-e487
[184] – Higgins, JP ∙ Soares-Weiser, K ∙ López-López, JA ∙ et al.
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
BMJ. 2016; 355, i5170
[185] – Fisker, AB ∙ Thysen, SM
Non-live pentavalent vaccines after live measles vaccine may increase mortality.
Vaccine. 2018; 36:6039-6042
[186] – Hirve, S ∙ Bavdekar, A ∙ Juvekar, S ∙ et al.
Nonspecific and sex-differential Effects of Vaccinations on Child Survival in Rural Western India
Vaccine. 2012; 30:7300-7308
[187] – Aaby, P ∙ Nielsen, J ∙ Benn, CS ∙ et al.
Sex-differential effects on mortality of BCG and diphtheria-tetanus-pertussis vaccines in a rural area with high vaccination coverage: observational study from Senegal
Trans R Soc Trop Med Hyg. 2016; 110:527-533
[188] – Aaby, P ∙ Andersen, A ∙ Ravn, H ∙ et al.
Co-administration of BCG and diphtheria-tetanus-pertussis (DTP) vaccinations may reduce infant mortality more than the WHO schedule of BCG first and then DTP. A reanalysis of demographic surveillance data from rural Bangladesh
EBioMedicine. 2017; 22:173-180
[189] – Sørup, S ∙ Benn, CS ∙ Poulsen, A ∙ et al.
Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register-based cohort study
Vaccine. 2016; 34:6172-6180
[190] – Ross, DA
Vitamin A and childhood mortality
Lancet. 1993; 342:861
[191] – Benn, CS ∙ Aaby, P ∙ Nielsen, J ∙ et al.
Does vitamin A supplementation interact with routine vaccinations? An Analysis of the Ghana Vitamin A Supplementation Trial
Am J Clin Nutr. 2009; 90:629-639
[192] – Benn, CS ∙ Martins, C ∙ Rodrigues, A ∙ et al.
The effect of vitamin A supplementation administered with missing vaccines during national immunization days in Guinea-Bissau
Int J Epidemiol. 2009; 38:304-311
[193] – Benn, CS ∙ Rodrigues, A ∙ Yazdanbakhsh, M ∙ et al.
Subsequent DTP vaccination may modify the effect of high-dose vitamin A supplementation administered with the BCG vaccine at birth.
Vaccine. 2009; 27:2891-2898
[194] – Fisker, AB ∙ Aaby, P ∙ Bale, C ∙ et al.
Does the effect of vitamin A supplements depend on vaccination status? An observational study from Guinea-Bissau
BMJ Open. 2012; 2, e000448
[195] – Benn, CS ∙ Martins, CL ∙ Fisker, AB ∙ et al.
Interaction between neonatal vitamin A supplementation and timing of measles vaccination: a retrospective analysis of three randomized trials from Guinea-Bissau
Vaccine. 2014; 32:5468-5474
[196] – Benn, CS ∙ Balé, C ∙ Sommerfelt, H ∙ et al.
Hypothesis: vitamin A supplementation and childhood mortality: amplification of the nonspecific effects of vaccines?
Int J Epidemiol. 2003; 32:822-828
[197] – Benn, CS ∙ Aaby, P ∙ Arts, RJ ∙ et al.
An enigma: why vitamin A supplementation does not always reduce mortality even though vitamin A deficiency is associated with increased mortality
Int J Epidemiol. 2015; 44:906-918
[198] – Fisker, AB ∙ Bale, C ∙ Rodrigues, A ∙ et al.
High-dose vitamin A with vaccination after 6 months of age: a randomized trial
Pediatrics. 2014; 134:e739-e748
[199] – On being a scientist. Committee on the Conduct of Science, National Academy of Sciences of the United States of America
Proc Natl Acad Sci USA. 1989; 86:9053-9074
[200] – Sørup, S ∙ Benn, CS ∙ Stensballe, LG ∙ et al.
Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact
Vaccine. 2015; 33:237-245
[201] – Aaby, P ∙ Andersen, A ∙ Martins, CL ∙ et al.
Does the oral polio vaccine have nonspecific effects on all-cause mortality? Natural experiments within a randomized controlled trial of early measles vaccine
[202] – Abdallah, AM ∙ Behr, MA
Evolution and strain variation in BCG
Adv Exp Med Biol. 2017; 1019:155-169
[203] – Curtis, N
BCG vaccination and all-cause neonatal mortality
Pediatr Infect Dis J. 2019; 38:195-197
[204] – Fish, EN ∙ Flanagan, KL ∙ Furman, D ∙ et al.
Changing the oral vaccine to the inactivated polio vaccine might increase mortality.
Lancet. 2016; 387:1054-1055
[205] – Aaby, P ∙ Benn, CS
Stopping live vaccines after disease eradication may increase mortality
Vaccine. 2020; 38:10-14
[206] – Kleinnijenhuis, J ∙ Quintin, J ∙ Preijers, F ∙ et al.
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.
Proc Natl Acad Sci USA. 2012; 109:17537-17542
[207] – Arts, RJW ∙ Moorlag, S ∙ Novakovic, B ∙ et al.
BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity
Cell Host Microbe. 2018; 23:89-100.e5
[208] – Walk, J ∙ de Bree, LCJ ∙ Graumans, W ∙ et al.
Outcomes of controlled human malaria infection after BCG vaccination
Nat Commun. 2019; 10:874
[209] – Uthayakumar, D ∙ Paris, S ∙ Chapat, L ∙ et al.
Nonspecific effects of vaccines illustrated through the BCG example: from observations to demonstrations
Front Immunol. 2018; 9, 2869
[210] – Leentjens, J ∙ Kox, M ∙ Stokman, R ∙ et al.
BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study
J Infect Dis. 2015; 212:1930-1938
[211] – lok, BA ∙ Jensen, KJ ∙ Aaby, P ∙ et al.
Opposite effects of vaccinia and modified vaccinia Ankara on trained immunity
Eur J Clin Microbiol Infect Dis. 2019; 38:449-456
[212] – Blok, BA ∙ de Bree, LCJ ∙ Diavatopoulos, DA ∙ et al.
Interacting nonspecific immunological effects of BCG and TDAPF vaccinations: an explorative randomized trial
Clin Infect Dis. 2019; 70:455-463
[213] – Noho-Konteh, F ∙ Adetifa, JU ∙ Cox, M ∙ et al.
Sex-differential non-vaccine-specific immunological effects of diphtheria-tetanus-pertussis and measles vaccination
Clin Infect Dis. 2016; 63:1213-1226
[214] – Aaby, P ∙ Rodrigues, A ∙ Biai, S ∙ et al.
Oral polio vaccination and low case fatality at the pediatric ward in Bissau, Guinea-Bissau
Vaccine. 2004; 22:3014-3017
[215] – Kjærgaard, J ∙ Birk, NM ∙ Nissen, TN ∙ et al.
Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial
Pediatr Res. 2016; 80:681-685
[216] – Thøstesen, LM ∙ Kjaergaard, J ∙ Pihl, GT ∙ et al.
Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial
Allergy. 2018; 73:498-504
[217] – Berendsen, MLT ∙ Øland, CB ∙ Bles, P ∙ et al.
Maternal priming: bacillus Calmette-Guérin (BCG) vaccine scarring in mothers enhances the survival of their child with a BCG vaccine scar
J Pediatric Infect Dis Soc. 2020; 9:166-172
[218] – Mawa, PA ∙ Webb, EL ∙ Filali-Mouhim, A ∙ et al.
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
Vaccine. 2017; 35:273-282
[219] – Arts, RJ ∙ Blok, BA ∙ van Crevel, R ∙ et al.
Vitamin A induces inhibitory histone methylation modifications, and down-regulates trained immunity in human monocytes.
J Leukoc Biol. 2015; 98:129-136
[220] – Stephensen, CB
Vitamin A, infection, and immune function
Annu Rev Nutr. 2001; 21:167-192
[221] – Villamor, E ∙ Fawzi, WW
Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes
Clin Microbiol Rev. 2005; 18:446-464
[222] – Benn, CS ∙ Aaby, P ∙ Fisker, AB
Neonatal vitamin A: time to move on?
Lancet. 2015; 386:132-133
[223] – Shann, F
Nonspecific effects of vaccines and the reduction of mortality in children
Clin Ther. 2013; 35:109-114
[224] – WHO
Meeting of the Strategic Advisory Group of Experts on immunization, April 2014—conclusions and recommendations
Wkly Epidemiol Rec. 2014; 89:221-236
[225] – Lawlor, DA ∙ Tilling, K ∙ Davey Smith, G
Triangulation in aetiological epidemiology
Int J Epidemiol. 2016; 45:1866-1886
[226] – Shann, F
Editorial commentary: different STRAINS of the bacillus Calmette-Guérin vaccine have very different effects on tuberculosis and unrelated infections
Clin Infect Dis. 2015; 61:960-962
[227] – Boehm, BE ∙ Cornell, JE ∙ Wang, H ∙ et al.
Efficacy of bacillus Calmette-Guérin Strains for treatment of nonmuscle invasive bladder cancer: a systematic review and network meta-analysis
J Urol. 2017; 198:503-510
[228] – Storgaard, L ∙ Rodrigues, A ∙ Martins, C ∙ et al.
Development of BCG scar and subsequent morbidity and mortality in rural Guinea-Bissau
Clin Infect Dis. 2015; 61:950-959
[229] – Kaufmann, E ∙ Sanz, J ∙ Dunn, JL ∙ et al.
BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis
Cell. 2018; 172:176-190
[230] – Gessner, BD ∙ Knobel, DL ∙ Conan, A ∙ et al.
Could the RTS, S/AS01 meningitis safety signal be a protective effect of the rabies vaccine?
Vaccine. 2017; 35:716-721
[231] – Knobel, DL ∙ Arega, S ∙ Reininghaus, B ∙ et al.
Rabies vaccine is associated with decreased all-cause mortality in dogs
Vaccine. 2017; 35:3844-3849
[232] – Arega, S ∙ Conan, A ∙ Sabeta, CT ∙ et al.
Rabies vaccination of 6-week-old puppies born to immunized mothers: a randomized controlled trial in a high-mortality population of owned, free-roaming dogs
Trop Med Infect Dis. 2020; 5:45
[233] – Benn, CS ∙ Netea, MG ∙ Selin, LK ∙ et al.
A small jab—a big effect: nonspecific immunomodulation by vaccines
Trends Immunol. 2013; 34:431-439
[234] – Saadatian-Elahi, M ∙ Aaby, P ∙ Shann, F ∙ et al.
Heterologous vaccine effects
Vaccine. 2016; 34:3923-3930
[235] – Cauchi, S ∙ Locht, C
Nonspecific effects of live attenuated pertussis vaccine against heterologous infectious and inflammatory diseases
Front Immunol. 2018; 9, 2872
[236] – Pennington, SH ∙ Ferreira, DM ∙ Caamaño-Gutiérrez, E ∙ et al.
Nonspecific effects of oral vaccination with live-attenuated Salmonella Typhi strain Ty21a
Sci Adv. 2019; 5, eaau6849-eaau
[237] – Sánchez-Ramón, S ∙ Conejero, L ∙ Netea, MG ∙ et al.
Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations
Front Immunol. 2018; 9, 2936
[238] – Aaby, P ∙ Fisker, AB ∙ Björkman, A ∙ et al.
WHO’s rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?
BMJ. 2020; published online January 24.
[239] – WHO
Meeting of the Strategic Advisory Group of Experts on immunization, April 2016—conclusions and recommendations
Wkly Epidemiol Rec. 2016; 91:266-284
[240] – Rieckmann, A ∙ Benn, CS
The importance of randomised vs non-randomised trials
Lancet. 2019; 394:634
[241] – Shann, F
Re: Nonspecific effects of childhood vaccines. Rapid response
BMJ. 2016; 355, i5434
[242] – https://pubmed.ncbi.nlm.nih.gov/24864348/
[243] – https://pubmed.ncbi.nlm.nih.gov/27922031/
[244] – https://pubmed.ncbi.nlm.nih.gov/19999831/
[245] – https://pubmed.ncbi.nlm.nih.gov/28580777/
[246] – https://pubmed.ncbi.nlm.nih.gov/4172852/
[247] – https://pubmed.ncbi.nlm.nih.gov/11582877/
[248] – Tuberculosis susceptibility and protection in children. Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Lancet Infect Dis. 2019 Mar;19(3):e96-e108. doi: 10.1016/S1473-3099(18)30157-9. Epub 2018 October 12. PMID: 30322790
[249] – The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau. Rasmussen SM, Biering-Sørensen S, Byberg S, Andersen A, Bjerregaard-Andersen M, Rodrigues A, Benn CS, Martins CL, Aaby P. BMC Pediatr. 2016 Dec 3;16(1):199. doi: 10.1186/s12887-016-0738-z. PMID: 27912735
[250] – A review of COVID-19 vaccines in development: 6 months into the pandemic. Sanicas M, Sanicas M, Diop D, Montomoli E. Pan Afr Med J. 2020 October 5;37:124. doi: 10.11604/pamj.2020.37.124.24973. eCollection 2020. PMID: 33425157
[251] – Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool. Karp CL, Wilson CB, Stuart LM. Immunol Rev. 2015 Mar;264(1):363-81. doi: 10.1111/imr.12270. PMID: 25703572
[252] – Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau. Varma A, Jensen AKG, Thysen SM, Pedersen LM, Aaby P, Fisker AB. BMC Public Health. 2019 Nov 11;19(1):1506. Doi: 10.1186/s12889-019-7813-y. PMID: 31711464
[254] – https://www.sciencedirect.com/science/article/abs/pii/B9780323790581000037
[255] – https://www.sciencedirect.com/topics/medicine-and-dentistry/pathogen
[257] – https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/atopy
[259] – https://www.sciencedirect.com/topics/medicine-and-dentistry/cancer
[260] – https://www.sciencedirect.com/topics/medicine-and-dentistry/degenerative-disease
[262] – https://www.sciencedirect.com/topics/medicine-and-dentistry/immunological-memory
[263] – https://blog.maryannedemasi.com/p/do-covid-19-vaccines-save-lives
[264] – https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4072489
[265] – https://blog.maryannedemasi.com/p/rfk-jrs-confirmation-hearing-highlights
[266] – https://www.skyhorsepublishing.com/9781510762190/vaccines/
Critical Thinking Dispatch 
Leave a comment